Cherry consumption and decreased risk of recurrent gout attacks

Arthritis and Rheumatism

Volumn 64, Issue 12, 2012, Pages 4004-4011

  Zhang, Yuqing ^a   Neogi, Tuhina ^a   Chen, Clara ^a   Chaisson, Christine ^a   Hunter, David J ^b,c   Choi, Hyon K ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHERRY EXTRACT; COLCHICINE; CORTICOSTEROID; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PURINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOLLOW UP; FOOD INTAKE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK REDUCTION; SYSTEMIC THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; COMORBIDITY; CROSS-OVER STUDIES; EATING; FEMALE; FOLLOW-UP STUDIES; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; PRUNUS; RECURRENCE; RISK FACTORS; SEX FACTORS;

EID: 84868478394     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34677     Document Type: Article

References (32)

1. Zhu Y, Pandya BJ, Choi HK,. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-41.
2. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE,. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29: 2403-6. (Pubitemid 35266034)
3. Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y,. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006; 33: 104-9. (Pubitemid 43054289)
4. Gutman AB,. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum 1973; 16: 431-45.
5. Jacob RA, Spinozzi GM, Simon VA, Kelley DS, Prior RL, Hess-Pierce B, et al. Consumption of cherries lowers plasma urate in healthy women. J Nutr 2003; 133: 1826-9. (Pubitemid 36666520)
6. Haidari F Jr, Mohammad Shahi M, Keshavarz SA, Rashidi MR,. Inhibitory effects of tart cherry (Prunus cerasus) juice on xanthine oxidoreductase activity and its hypouricemic and antioxidant effects on rats. Malays J Nutr 2009; 15: 53-64.
7. Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI,. Novel antioxidant compounds from tart cherries (Prunus cerasus). J Nat Prod 1999; 62: 86-8. (Pubitemid 29071382)
8. Seeram NP, Momin RA, Nair MG, Bourquin LD,. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 2001; 8: 362-9. (Pubitemid 32983056)
9. Kirakosyan A, Seymour EM, Urcuyo-Llanes DE, Kaufman PB, Bolling SF,. Chemical profile and antioxidant capacities of tart cherry products. Food Chem 2009; 115: 20-5.
10. Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE,. Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 2006; 136: 981-6.
11. Schlesinger N, Rabinowitz R, Schlesinger MH,. Effect of cherry juice concentration on the secretion of interleukins by human monocytes exposed to monosodium urate crystals in vitro [abstract]. Ann Rheum Dis 2010; 69 Suppl 3: iii610.
12. He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, et al. Anti-inflammatory and anti-oxidative effects of cherries on Freund's adjuvant-induced arthritis in rats. Scand J Rheumatol 2006; 35: 356-8. (Pubitemid 44601068)
13. US Food and Drug Administration. List of firms receiving warning letters regarding cherry and other fruit-based products with disease claims in labeling. URL: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ ComplianceEnforcement/ucm081724.htm.
14. Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA,. Patients and providers view gout differently: a qualitative study. Chronic Illn 2010; 6: 263-71.
15. Zhang Y, Chaisson CE, McAlindon T, Woods R, Hunter DJ, Niu J, et al. The online case-crossover study is a novel approach to study triggers for recurrent disease flares. J Clin Epidemiol 2007; 60: 50-5. (Pubitemid 44873186)
16. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE, for the Determinants of Myocardial Infarction Onset Study Investigators. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med 1993; 329: 1677-83. (Pubitemid 23346917)
17. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF,. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
18. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G,. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093-103. (Pubitemid 38298989)
19. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW,. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010; 62: 1060-8.
20. Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011; 306: 711-20.
21. So A, De Meulemeester M, Pikhlak A, Yucel AE, Richard D, Murphy V, et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study. Arthritis Rheum 2010; 62: 3064-76.
22. Gaffo AL, Schumacher HR Jr, Saag KG, Taylor WJ, Allison J, Chen L, et al. Developing American College of Rheumatology and European League Against Rheumatism criteria for definition of a flare in patients with gout [abstract]. Arthritis Rheum 2009; 60 Suppl: S563.
23. Van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A,. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 1995; 214: 755-9.
24. Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 2005; 52: 1843-7. (Pubitemid 40852893)
25. Choi HK, Gao X, Curhan G,. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009; 169: 502-7.
26. Gao X, Curhan G, Forman JP, Ascherio A, Choi HK,. Vitamin C intake and serum uric acid concentration in men. J Rheumatol 2008; 35: 1853-8.
27. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-24. (Pubitemid 44620440)
28. Maclure M,. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-53.
29. McAlindon T, Formica M, Kabbara K, LaValley M, Lehmer M,. Conducting clinical trials over the internet: feasibility study. BMJ 2003; 327: 484-7. (Pubitemid 37056198)
30. Lorig KR, Laurent DD, Deyo RA, Marnell ME, Minor MA, Ritter PL,. Can a back pain e-mail discussion group improve health status and lower health care costs? A randomized study. Arch Intern Med 2002; 162: 792-6. (Pubitemid 34273302)
31. Choi HK, Curhan G,. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336: 309-12. (Pubitemid 351278368)
32. Choi JW, Ford ES, Gao X, Choi HK,. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008; 59: 109-16. (Pubitemid 351171885)